Department of Internal Medicine, Seoul National University Hospital.
Department of Internal Medicine, Seoul National University Bundang Hospital.
Circ J. 2018 Nov 24;82(12):2970-2975. doi: 10.1253/circj.CJ-18-0218. Epub 2018 Oct 4.
There is little evidence that focuses on the ethnic variability of clinical risk factors for thromboembolism (TE) in atrial fibrillation (AF). We aimed to investigate the effect of each traditional risk factor in the Korean AF population.
Medical records of 12,876 consecutive patients (aged >18 years) newly diagnosed and followed up with non-valvular AF from 2000 to 2013 were reviewed. TE events, including ischemic stroke and systemic embolism, were investigated for risk factor validation. Among the total of 12,876 patients, 1,390 (10.8%) had TE events. In univariate/multivariate analysis adjusting for clinical factors and antithrombotic medications, traditional risk factors included in the CHADS-VASc scheme showed statistical significance, except for female sex, which was not a predictor of events. Additionally, chronic kidney disease (CKD; hazard ratio 1.62, P<0.001) was shown to be an independent predictor of TE events. Based on the analysis, we developed a novel stratification system, CHADS-VAK, omitting the female sex category and adding CKD. The new scoring system showed greater discrimination in event rates between score 0 and 1 patients.
Female sex was not associated with TE events in a Korean non-valvular AF population. The novel CHADS-VAK scoring system, with substitution of CKD for female sex, might be more appropriate for the Korean population.
目前针对房颤患者血栓栓塞(TE)的临床风险因素的种族差异,相关证据较少。我们旨在研究每种传统风险因素在韩国房颤人群中的作用。
回顾了 2000 年至 2013 年间连续 12876 例(年龄>18 岁)新诊断和随访的非瓣膜性房颤患者的病历。研究了 TE 事件(包括缺血性卒中和全身栓塞)的危险因素验证。在总共 12876 例患者中,有 1390 例(10.8%)发生了 TE 事件。在调整临床因素和抗血栓药物的单因素/多因素分析中,CHADS-VASc 方案中包含的传统危险因素具有统计学意义,但女性性别除外,其不是事件的预测因素。此外,慢性肾脏病(CKD;风险比 1.62,P<0.001)是 TE 事件的独立预测因素。在此基础上,我们开发了一种新的分层系统 CHADS-VAK,排除了女性类别,并添加了 CKD。新的评分系统在 0 分和 1 分患者之间的事件发生率方面显示出更好的区分度。
在韩国非瓣膜性房颤人群中,女性性别与 TE 事件无关。新型 CHADS-VAK 评分系统用 CKD 替代女性,可能更适合韩国人群。